[HTML][HTML] Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?
R Hellemans, JL Bosmans, D Abramowicz - American Journal of …, 2017 - Elsevier
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans… - American Journal of …, 2016 - europepmc.org
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
[HTML][HTML] Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans… - American Journal of …, 2017 - ncbi.nlm.nih.gov
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL 2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans… - American Journal of …, 2017 - Wiley Online Library
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
[HTML][HTML] Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans… - American Journal of …, 2017 - amjtransplant.org
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?
R Hellemans, JL Bosmans… - American journal of …, 2017 - repository.uantwerpen.be
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans… - American journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte …
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL 2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans, D Abramowicz - American Journal of …, 2016 - infona.pl
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?
R Hellemans, JL Bosmans… - American Journal of …, 2016 - europepmc.org
Induction therapy with antilymphocyte biological agents is widely used after kidney
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …
transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte …